Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)

Not yet recruiting

Phase 1/2 Results N/A

Main Contacts

Name Phone E-mail
Ronen R. Leker, MD, FAHA Principal Investigator
Arnon Aharon Contact 972545500702 arnon@rnd-is.com

Other Locations

Name City State Country Status
Hadassah Medical Center, Jerusalem Israel Unknown_status_icon